# LENSAR, Inc.: filings

LNSR · Nasdaq · CIK 1320350 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lnsr.md) · [Financials](/companies/lnsr/financials.md) · [Filings](/companies/lnsr/filings.md) · [Insiders](/companies/lnsr/insiders.md)

## Reports and events: 97 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 106, 8-K 58, 10-Q 18, SC 13G/A 16, 3 13, D 12, DEFA14A 11, CORRESP 7, DEF 14A 7, SC 13G 7, 10-K 6, S-8 6, SCHEDULE 13G/A 5, UPLOAD 5, ARS 4, D/A 3, 10-K/A 2, 10-Q/A 2, 424B5 2, 8-K/A 2, EFFECT 2, PX14A6G 2, S-3 2, SEC STAFF LETTER 2, 10-12B 1, 10-12B/A 1, 144 1, 424B3 1, CERT 1, DEFM14A 1, DRS 1, DRS/A 1, DRSLTR 1, PRE 14A 1, PREM14A 1, REGDEX 1, S-3/A 1, SC 13D 1, SCHEDULE 13D/A 1, SCHEDULE 13G 1, SEC STAFF ACTION 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 16:30 ET | [10-Q](/filings/0001193125-26-349315.md) | Quarterly report, period 2026-06-30 | 0001193125-26-349315 |
| 2026-08-13 | 07:10 ET | [8-K](/filings/0001193125-26-347859.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-347859 |
| 2026-08-10 | 16:05 ET | [8-K](/filings/0001193125-26-342330.md) | 5.07 Shareholder vote results | 0001193125-26-342330 |
| 2026-06-23 | 16:20 ET | [DEF 14A](/filings/0001193125-26-279484.md) | Proxy statement, period 2026-06-23 | 0001193125-26-279484 |
| 2026-05-29 | 16:05 ET | [8-K](/filings/0001193125-26-248230.md) | 5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events | 0001193125-26-248230 |
| 2026-05-08 | 16:00 ET | [10-Q](/filings/0001193125-26-214571.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214571 |
| 2026-05-08 | 07:05 ET | [8-K](/filings/0001193125-26-213268.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-213268 |
| 2026-04-30 | 16:30 ET | [10-K/A](/filings/0001193125-26-197477.md) | Annual report, amended, period 2025-12-31 | 0001193125-26-197477 |
| 2026-04-15 | 16:30 ET | [8-K](/filings/0001193125-26-157105.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-157105 |
| 2026-03-31 | 16:14 ET | [10-K](/filings/0001193125-26-134587.md) | Annual report, period 2025-12-31 | 0001193125-26-134587 |
| 2026-03-31 | 06:10 ET | [8-K](/filings/0001193125-26-133153.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-133153 |
| 2026-03-17 | 08:26 ET | [8-K](/filings/0001193125-26-109458.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-109458 |
| 2026-03-13 | 06:02 ET | [8-K/A](/filings/0001193125-26-104937.md) | 8.01 Other events | 0001193125-26-104937 |
| 2026-03-12 | 16:17 ET | [8-K](/filings/0001193125-26-104194.md) | 8.01 Other events | 0001193125-26-104194 |
| 2026-02-25 | 17:09 ET | [8-K](/filings/0001193125-26-072059.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-072059 |
| 2025-12-19 | 16:01 ET | [8-K](/filings/0001193125-25-326777.md) | 5.07 Shareholder vote results | 0001193125-25-326777 |
| 2025-11-06 | 16:01 ET | [10-Q](/filings/0001193125-25-269428.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269428 |
| 2025-11-06 | 07:15 ET | [8-K](/filings/0001193125-25-268073.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-268073 |
| 2025-11-05 | 07:00 ET | [DEF 14A](/filings/0001193125-25-265686.md) | Proxy statement, period 2025-10-24 | 0001193125-25-265686 |
| 2025-10-21 | 16:30 ET | [8-K](/filings/0001193125-25-245196.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001193125-25-245196 |
| 2025-08-07 | 16:05 ET | [10-Q](/filings/0001320350-25-000004.md) | Quarterly report, period 2025-06-30 | 0001320350-25-000004 |
| 2025-08-07 | 07:15 ET | [8-K](/filings/0000950170-25-104556.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-104556 |
| 2025-07-02 | 16:00 ET | [8-K](/filings/0000950170-25-092921.md) | 5.07 Shareholder vote results | 0000950170-25-092921 |
| 2025-05-22 | 16:43 ET | [8-K](/filings/0001193125-25-125116.md) | 8.01 Other events | 0001193125-25-125116 |
| 2025-05-08 | 16:12 ET | [10-Q](/filings/0000950170-25-066964.md) | Quarterly report, period 2025-03-31 | 0000950170-25-066964 |
| 2025-05-08 | 16:01 ET | [8-K/A](/filings/0000950170-25-066893.md) | 9.01 Financial statements and exhibits | 0000950170-25-066893 |
| 2025-05-08 | 07:15 ET | [8-K](/filings/0000950170-25-066375.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066375 |
| 2025-04-30 | 16:05 ET | [10-K/A](/filings/0000950170-25-061029.md) | Annual report, amended, period 2024-12-31 | 0000950170-25-061029 |
| 2025-03-25 | 21:52 ET | [SCHEDULE 13D/A](/filings/0000950170-25-044695.md) | Ownership report, active investor, amended | 0000950170-25-044695 |
| 2025-03-24 | 08:11 ET | [8-K](/filings/0001193125-25-060906.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-060906 |
| 2025-02-27 | 16:01 ET | [10-K](/filings/0000950170-25-029003.md) | Annual report, period 2024-12-31 | 0000950170-25-029003 |
| 2025-02-27 | 07:30 ET | [8-K](/filings/0000950170-25-028363.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-028363 |
| 2024-11-07 | 17:25 ET | [10-Q](/filings/0000950170-24-123534.md) | Quarterly report, period 2024-09-30 | 0000950170-24-123534 |
| 2024-11-07 | 07:15 ET | [8-K](/filings/0000950170-24-122790.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-122790 |
| 2024-08-08 | 16:03 ET | [10-Q](/filings/0000950170-24-093862.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093862 |
| 2024-08-08 | 07:30 ET | [8-K](/filings/0000950170-24-093326.md) | 1.02 Termination of a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093326 |
| 2024-05-13 | 16:00 ET | [8-K](/filings/0000950170-24-058603.md) | 5.07 Shareholder vote results | 0000950170-24-058603 |
| 2024-05-09 | 16:00 ET | [10-Q](/filings/0000950170-24-056837.md) | Quarterly report, period 2024-03-31 | 0000950170-24-056837 |
| 2024-05-09 | 07:30 ET | [8-K](/filings/0000950170-24-056284.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-056284 |
| 2024-05-08 | 16:00 ET | [8-K](/filings/0000950170-24-055579.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-055579 |
| 2024-03-25 | 06:03 ET | [DEF 14A](/filings/0000950170-24-035579.md) | Proxy statement, period 2024-05-07 | 0000950170-24-035579 |
| 2024-03-04 | 16:01 ET | [10-K](/filings/0000950170-24-024807.md) | Annual report, period 2023-12-31 | 0000950170-24-024807 |
| 2024-03-04 | 07:30 ET | [8-K](/filings/0000950170-24-024351.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-024351 |
| 2024-02-26 | 16:30 ET | [8-K](/filings/0000950170-24-020190.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-24-020190 |
| 2024-02-06 | 16:30 ET | [8-K](/filings/0000950170-24-011745.md) | 5.02 Departure or appointment of officers or directors | 0000950170-24-011745 |
| 2023-11-09 | 16:35 ET | [10-Q](/filings/0000950170-23-062153.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062153 |
| 2023-11-09 | 07:30 ET | [8-K](/filings/0000950170-23-061532.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-061532 |
| 2023-10-13 | 07:00 ET | [8-K](/filings/0000950170-23-053209.md) | 5.02 Departure or appointment of officers or directors | 0000950170-23-053209 |
| 2023-08-09 | 16:29 ET | [10-Q](/filings/0000950170-23-040659.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040659 |
| 2023-08-09 | 07:30 ET | [8-K](/filings/0000950170-23-040141.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-040141 |

Page 1 of 2. [Older](/companies/lnsr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.